Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wei Zhang
Observed name:
Zhang, Wei
Institutions:
Åbo Akademi University,
University of Turku,
University of Manchester
Observed institutions:
Åbo Akademi University,
University of Turku,
University of Manchester
ORCID:
0000-0002-3826-7128
Observed ORCID:
0000-0002-3826-7128
OpenAlex ID:
A5100441622
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models
2023
·
Chun Wai Wong
, Christos Evangelou
, et al.
·
Nature Communications
·
48
PDF
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion
2021
·
Qiuping Xu
, Jingwei Zhang
, et al.
·
Oncogene
·
39
PDF
eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways
2023
·
Ibrahim Ahmed
, Shen-Hsi Yang
, et al.
·
eLife
·
19
PDF
Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2022
·
Jingwei Zhang
, Adam J. Pearson
, et al.
·
Cancer Research Communications
·
12
PDF
Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma
2022
·
Wenchao Gu
, Shaocong Mo
, et al.
·
Cancers
·
4
PDF
NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition
2025
·
Wei Zhang
, Jiaqing Lang
, et al.
·
Oncogene
·
3
PDF
Targeting Cancer Drug-Tolerant Persister Cells in Minimal Residual Disease
2025
·
Wei Zhang
, Sorayut Chattrakarn
, et al.
·
International Journal of Drug Discovery and Pharmacology
·
3
PDF
XMD8-92 and JWG-045 exhibit anti-ferroptotic activities, independently of inhibiting ERK5
2026
·
Wei Zhang
, Karmern Kan
, et al.
·
Scientific Reports
·
1
PDF
Eukaryotic translation initiation factor 3d regulates stress granule assembly via its RNA binding domain
2025
·
Alan Whitmarsh
, Jiaqing Lang
, et al.
·
Research Square
Eukaryotic translation initiation factor 3d regulates stress granule assembly via its RNA binding domain
2025
·
Jiaqing Lang
, Aristeidis P. Sfakianos
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Investigating the mechanisms of cancer cell adaptation to survive therapeutic pressure
2025
·
Zhang, Wei
·
Research Explorer (The University of Manchester)
Data from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S7 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S8 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S9 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S6 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S3 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S2 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S5 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S11 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
PDF
Figure S4 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S10 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S1 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
Figure S3 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
2023
·
Jingwei Zhang
, Adam J. Pearson
, et al.
PDF
Author response: eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways
2023
·
Ibrahim Ahmed
, Shen-Hsi Yang
, et al.
·
eLife
Show more works
View as search
Works count:
25
Citation count:
129
H-index:
4
I10-index:
4
Year
Topic
Type